Taipei, Taiwan

Liang-Ting Lin

This inventor holds 2 USPTO granted patents. Top assignees: Institute of Nuclear Energy Research, National Yang Ming Chiao Tung University. Active years: 2017-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liang-Ting Lin. Retrieved from https://idiyas.com/inventor/liang-ting-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Liang-Ting Lin: Advancements in Fluorescent Proteins and Radiopharmaceuticals

Introduction

Liang-Ting Lin is a prominent inventor based in Taipei, Taiwan, recognized for his contributions to the fields of biochemistry and medical science. With an impressive portfolio of two patents, Lin focuses on innovations that harness the power of fluorescent proteins and radiopharmaceuticals to address significant health challenges.

Latest Patents

Liang-Ting Lin’s latest patents showcase his ingenuity and depth of knowledge in biomedical applications. The first patent introduces a fluorescent fusion protein designed to enhance fluorescence properties. This innovative protein consists of a first fluorescent protein with a specific emission wavelength and a second fluorescent protein with both excitation and emission wavelengths. A crucial element of this invention is a linker peptide that connects the two proteins, allowing them to work cohesively. Remarkably, this fluorescent fusion protein demonstrates stronger fluorescence without the presence of biliverdin (BV).

The second patent involves a kit for the preparation of targeted radiopharmaceuticals, which plays a vital role in cancer treatment. This kit provides an efficient method for utilizing radiopharmaceuticals that consist of a radio-nuclear loading on liposomes. These radiopharmaceuticals are designed to inhibit tumor growth and metastatic progression in various types of cancer, including head and neck cancer, lung cancer, and brain cancer. This innovation holds promise for improving therapeutic outcomes for patients battling these serious conditions.

Career Highlights

Throughout his career, Liang-Ting Lin has made significant strides in his professional journey, working at renowned institutions such as National Yang-Ming University and the Institute of Nuclear Energy Research, affiliated with the Atomic Energy Council, Executive Yuan. His work in these reputable entities has contributed greatly to his expertise and the success of his inventions.

Collaborations

In the course of his career, Lin has collaborated with fellow researchers Yi-Jang Lee and Bo-Sheng Wang. These partnerships have facilitated the exchange of ideas and bolstered the development of innovative technologies in their respective fields.

Conclusion

Liang-Ting Lin stands as a testament to the vital role of inventors in advancing science and technology. His patents in fluorescent proteins and targeted radiopharmaceuticals illustrate the possibilities that innovations can bring to healthcare. As he continues his work, Lin's contributions hold the potential to shape the future of therapeutic treatments and significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…